PF 05175157
CAS: 1301214-47-0
Ref. 3D-BCC21447
| 5mg | 181.00 € | ||
| 10mg | 262.00 € | ||
| 25mg | 460.00 € | ||
| 50mg | 655.00 € | ||
| 100mg | 1,000.00 € |
Product Information
PF 05175157 is a potent small molecule, orally active inhibitor of fatty acid synthase (FAS) that causes hepatocyte steatosis in vitro and in vivo. PF 05175157 is also an inhibitor of the enzyme stearoyl-CoA desaturase 1 (SCD1), which converts saturated to monounsaturated fatty acids. The compound has been shown to reduce liver and body weight gain in mice fed a high-fat diet, as well as to improve dyslipidemia and hepatic steatosis. PF 05175157 has been evaluated clinically for the treatment of obesity, type 2 diabetes mellitus, and nonalcoholic fatty liver disease.
PF 05175157 was granted orphan drug designation for the treatment of pediatric chronic kidney disease by the FDA on June 6, 2015.
Chemical properties
Technical inquiry about: 3D-BCC21447 PF 05175157
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
